Filing Details

Accession Number:
0001140361-10-043899
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-11-05 15:01:42
Reporting Period:
2010-11-03
Filing Date:
2010-11-05
Accepted Time:
2010-11-05 15:01:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1048477 Biomarin Pharmaceutical Inc BMRN Pharmaceutical Preparations (2834) 680397820
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1274826 Robert Baffi C/O Biomarin Pharmaceutical Inc.
105 Digital Drive
Novato CA 94949
Evp, Technical Operations No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-10-29 473 $11.64 69,713 No 5 A Direct
Common Stock Disposition 2010-11-03 2,000 $25.24 67,713 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 A Direct
No 4 S Direct
Footnotes
  1. The reporting person is voluntarily reporting the acquisition of shares of the issuer's Employee Stock Purchase Program ("ESPP"), for the ESPP purchase period of May 1, 2010 to October 29, 2010.
  2. In accordance with ESPP, these shares have been purchased at 85% of the closing price of issuer's common stock on April 30, 2010.
  3. The price in Column 4 is a weighted average price. The prices actually received range from $25.24 to $25.251. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.